Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1996
05/28/1996US5521201 Method for treatment of atherosclerosis
05/28/1996US5521199 Piperidinyl compounds as neurokinin receptor antagonists
05/28/1996US5521198 Methods of inhibiting autoimmune diseases
05/28/1996US5521197 Analgesics using serotonin antagonist
05/28/1996US5521196 5-HT1F agonists for the treatment of migraine
05/28/1996US5521194 Antiproliferative agent for restenosis treatment
05/28/1996US5521191 Method for treatment of arterial stenosis
05/28/1996US5521189 Pyrimidine compounds as antiprotozoa agents
05/28/1996US5521187 Phosphodiesterase inhibitors, antiallergens and atopic diseases
05/28/1996US5521186 Apolipoprotein-β synthesis inhibitors
05/28/1996US5521185 Methods for inhibiting graft rejection and IL-1 production
05/28/1996US5521183 Use of 5-HT ligands as anti-pruritic agents
05/28/1996US5521182 1,2,3,4 tetrahydropteridinone cyclic amide derivatives
05/28/1996US5521178 Combination medication containing flupirtin and morphine for the treatment of pain and the prevention of morphine dependence
05/28/1996US5521177 Angiotensin antagonist for cardiovascular disorders such as ischemia or central nervous system disorders such as cognitive functions, depression, alzheimer's disease or parkinson's syndrome
05/28/1996US5521175 Benzodiazepine derivatives
05/28/1996US5521173 Tricyclic benzazepine vasopressin antagonists
05/28/1996US5521172 Benzothiophene ketones with benzene derivatives
05/28/1996US5521171 Copper complex with heterocyclic carboxylic acid
05/28/1996US5521170 Benzamide derivatives and pharmaceutical composition comprising the same
05/28/1996US5521168 Treating glaucoma
05/28/1996US5521167 Cyclopentanperhydrophenanthren-17β-(hydroxy or alkoxy)-17α-(Aryl or heterocyclyl)-3β-derivatives active on the cardiovascular system, and pharmaceutical compositions containing same
05/28/1996US5521166 Contraceptives, hormone replacement therapy
05/28/1996US5521164 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
05/28/1996US5521160 Compounds for treatment of atheriosclerosis in blood vessels and prevention of restenosis after angioplasty
05/28/1996US5521155 Antibiotic active against grampositive bacteria
05/28/1996US5521070 DNA sequence coding for human factor IX or a similar protein, expression vector, transformed cells, method for preparing factor IX and corresponding products obtained
05/28/1996US5520932 Fine-milled colestipol hydrochloride
05/28/1996US5520931 Controlled release morphine preparation
05/28/1996US5520928 Pharmaceutical composition of ticlopidine hydrochloride
05/28/1996US5520927 Method for the preparation of sustained release somatotropin and product produced thereby
05/28/1996US5520926 Wound dressings
05/28/1996US5520918 Salicylic acid, lactic acid
05/28/1996US5520905 Cosmetic or dermatological preparation comprising delta-aminolevulinic acid content as an active ingredient
05/28/1996CA2072573C Treatment of human retroviral infections with 2',3'-dideoxyinosine
05/28/1996CA2041330C Percutaneously absorbable eperisone or tolperisone preparation
05/28/1996CA2000401C Percutaneous pharmaceutical preparation
05/28/1996CA1338352C 2-substituted quinolines
05/26/1996CA2163724A1 2-amino-1,3-thiazines as inhibitors of nitric oxide synthase
05/25/1996CA2163598A1 Substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic, and medicament containing them
05/24/1996CA2163466A1 Fortified fruit juices
05/23/1996WO1996015240A2 Ribozyme analogs
05/23/1996WO1996015234A2 Lipid-splitting enzyme
05/23/1996WO1996015226A1 Regulation of neural stem cell proliferation
05/23/1996WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues
05/23/1996WO1996015131A1 Macrocyclic lactone compounds and their production process
05/23/1996WO1996015130A1 Bicyclic oxazine and thiazine oxazolidinone antibacterials
05/23/1996WO1996015129A1 Oxazolyl- and thiazolylimidazo-benzo- and thienodiazepines and their use as medicaments
05/23/1996WO1996015128A2 6-ARYL PYRIDO[2,3-d]PYRIMIDINES AND NAPHTHYRIDINES FOR INHIBITING PROTEIN TYROSINE KINASE MEDIATED CELLULAR PROLIFERATION
05/23/1996WO1996015127A1 Pyridazinoquinoline compounds
05/23/1996WO1996015126A1 Furan derivatives for inhibiting pneumocystis carinii pneumonia, giardia lamblia and cryptosporidium parvum
05/23/1996WO1996015125A1 Nonpeptide endothelin antagonists
05/23/1996WO1996015124A1 Hydrate for medicinal use
05/23/1996WO1996015123A1 Pyridine modulators of acetylcholine receptors
05/23/1996WO1996015121A1 Use of dioxomorpholines to combat endoparasites, novel dioxomorpholines and process for their production
05/23/1996WO1996015120A1 Aminotetrazole derivatives useful as nitric oxide synthase inhibitors
05/23/1996WO1996015118A1 Aniline derivatives
05/23/1996WO1996015109A1 Endothelin antagonists
05/23/1996WO1996015108A1 Pyrrolidinyl di-carboxylic acid derivatives as metabotropic glutamate receptor agonists
05/23/1996WO1996015106A1 Aryloxycycloalkenyl and aryloxyiminocycloalkenylhydroxyureas as 5-lipoxygenase inhibitors
05/23/1996WO1996015103A1 Diaminocyclobutene-3,4-diones
05/23/1996WO1996015101A1 Novel amino acid derivatives with improved multi-drug resistance activity
05/23/1996WO1996015098A1 Amine derivatives for treatment of skin disorders
05/23/1996WO1996015096A1 Substituted 4-biarylbutyric or 5-biarylpentanoic acids and derivatives as matrix metalloprotease inhibitiors
05/23/1996WO1996014876A1 Yeast-based delivery vehicles
05/23/1996WO1996014872A1 Novel complexes and their compositions
05/23/1996WO1996014868A1 Acne treating-wound healing compositions containing a pyruvate, an antioxidant and a mixture of fatty acids
05/23/1996WO1996014857A1 Multicatalytic protease inhibitors
05/23/1996WO1996014852A1 Composition of cisplatin in combination with 2,2'-dithio-bis(ethanesulfonate) (dimesna)
05/23/1996WO1996014851A1 Medicaments
05/23/1996WO1996014850A1 Decolorized carotenoid-cyclodextrin complexes
05/23/1996WO1996014848A1 Novel medicinal use
05/23/1996WO1996014847A1 Use of phosphonoacetic or-formic acids against human herpes virus -7 (hhv-7)
05/23/1996WO1996014846A1 Dihydropyrimidines and uses thereof
05/23/1996WO1996014845A1 Nk-1 receptor antagonists for the treatment of eye disorders
05/23/1996WO1996014844A1 Cyclic amidine analogs as inhibitors of nitric oxide synthase
05/23/1996WO1996014843A3 Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
05/23/1996WO1996014843A2 Pharmaceutical pyrazole compositions useful as inhibitors of protein kinases
05/23/1996WO1996014841A1 Antiviral and antitumor pharmaceutical compositions
05/23/1996WO1996014840A1 Use of menthyl lactate as a pain reliever
05/23/1996WO1996014839A1 Pharmaceutical composition comprising non-steroidal anti-inflammatory drugs
05/23/1996WO1996014838A1 Novel diacetyldapsone-containing compositions and the use thereof for the treatment of various disease states
05/23/1996WO1996014828A1 Hemorrhoidal compositions and method of use
05/23/1996WO1996014826A1 Lotion which is temporarily colored upon application
05/23/1996WO1996014748A1 AMELIORATION OF HUMAN ERECTILE DYSFUNCTION BY TREATMENT WITH iNOS, AND RELATED NOS AGENTS
05/23/1996WO1996014745A1 Eleutherobin and analogs thereof
05/23/1996WO1996014740A1 Synthetic media for blood components
05/23/1996WO1996014739A1 Compounds for the photodecontamination of pathogens in blood
05/23/1996WO1996014737A1 Treating red blood cell solutions with anti-viral agents
05/23/1996WO1996009831A3 Compositions containing at least one glucocorticoid in combination with a pulmonary surfactant for the treatment of irds and ards
05/23/1996WO1996009827A3 Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor
05/23/1996WO1996009826A3 Combination of prostacyclin with an estrogen or progestin for the prevention and treatment of atherosclerotic vascular disease including preeclampsia and for the treatment of hypertension, and for hormone replacement therapy
05/23/1996CA2224198A1 Novel amino acid derivatives with improved multi-drug resistance activity
05/23/1996CA2205307A1 Diaminocyclobutene-3,4-diones
05/23/1996CA2205206A1 Hydrate for drug use
05/23/1996CA2205019A1 Novel complexes and their compositions
05/23/1996CA2205016A1 Nk-1 receptor antagonists for the treatment of eye disorders
05/23/1996CA2204908A1 Lipid cleavage enzyme
05/23/1996CA2204898A1 Methods of inhibiting pneumocystis carini pneumonia, giardia lamblia, and cryptosporidum parvum and compounds useful therefor
05/23/1996CA2204886A1 Amelioration of human erectile dysfunction by treatment with inos, and related nos agents
1 ... 6914 6915 6916 6917 6918 6919 6920 6921 6922 6923 6924 6925 6926 6927 6928 6929 6930 6931 6932 6933 6934 ... 7860